Consensus Considerations and Good Practice Points for Use of Continuous Glucose Monitoring Systems in Hospital Settings.
Continuous glucose monitoring (CGM) systems provide frequent glucose measurements in interstitial fluid and have been used widely in ambulatory settings for diabetes management. During the coronavirus disease 2019 (COVID-19) pandemic, regulators in the U.S. and Canada temporarily allowed for CGM systems to be used in hospitals with the aim of reducing health care professional COVID-19 exposure and limiting use of personal protective equipment. As such, studies on hospital CGM system use have been possible. With improved sensor accuracy, there is increased interest in CGM usage for diabetes management in hospitals. Laboratorians and health care professionals must determine how to integrate CGM usage into practice. The aim of this consensus guidance document is to provide an update on the application of CGM systems in hospital, with insights and opinions from laboratory medicine, endocrinology, and nursing.
Authors
- Allison A. Venner (ORCID: https://orcid.org/0000-0002-2865-7093)
- Julie Shaw (ORCID: https://orcid.org/0000-0003-3983-8487)
- Raveendhara R. Bannuru (ORCID: https://orcid.org/0000-0002-8069-5783)
- Huang Yun (ORCID: https://orcid.org/0000-0003-3078-4304)
- Stefan Pleus (ORCID: https://orcid.org/0000-0003-4629-7754)
- Angela W.S. Fung (ORCID: https://orcid.org/0000-0002-3537-8623)
- Rebecca Longo (ORCID: https://orcid.org/0000-0003-0804-3913)
- Jane Jeffrie Seley (ORCID: https://orcid.org/0000-0003-1582-4320)
- Nuha A. ElSayed (ORCID: https://orcid.org/0000-0003-1217-4916)
- Nichole L Korpi-Steiner (ORCID: https://orcid.org/0009-0007-7924-599X)
- Kendall Rogers
- Lori Beach (ORCID: https://orcid.org/0000-0002-0842-0558)
- Guillermo E. Umpierrez (ORCID: https://orcid.org/0000-0002-3252-5026)
- Fiona Thompson-Hutchison
- Samantha M. Logan (ORCID: https://orcid.org/0000-0002-3065-3155)
- Zachary Taxin (ORCID: https://orcid.org/0000-0003-1320-657X)
- Nicole V. Tolan (ORCID: https://orcid.org/0000-0002-7239-1843)
- Anna K. Füzéry
- Nam K. Tran (ORCID: https://orcid.org/0000-0003-1565-0025)
- Dylan MacKay (ORCID: https://orcid.org/0000-0002-0751-1634)
- Guido Freckmann (ORCID: https://orcid.org/0000-0002-0406-9529)
- Jeremy Gilbert (ORCID: https://orcid.org/0000-0001-7456-9396)
- Lisa Maks
Institutions
- University of North Carolina at Chapel Hill (US)
Publication Details
- Journal
- Carolina Digital Repository (University of North Carolina at Chapel Hill)
- Published
- 2024-11-13
- DOI
- https://doi.org/10.17615/0jbd-gd82
- Primary Topic
- Diabetes Management and Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Eli Lilly and Company
- Dexcom
- Novo Nordisk
- Lilly Deutschland